Biafo Industries Limited (PSX:BIFO)

CTI BioPharma Ratios and Metrics

Market cap in millions PKR. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	8,689	4,731	3,061	3,108	5,298	5,008
Market Cap Growth	67.65%	54.55%	-1.49%	-41.34%	5.78%	18.20%
Enterprise Value	8,751	4,872	3,163	3,616	5,339	5,115
Last Close Price	187.33	98.99	59.65	56.21	93.75	85.26
PE Ratio	50.52	16.04	5.04	12.55	20.85	20.37
Forward PE	-	11.56	11.56	11.56	11.56	11.56
PS Ratio	3.47	1.97	1.13	1.86	3.60	3.16
PB Ratio	2.79	1.61	1.04	1.33	3.43	3.39
P/TBV Ratio	2.80	1.62	1.05	1.33	3.43	3.39
P/FCF Ratio	37.17	9.52	10.74	-	103.48	1308.96
P/OCF Ratio	32.27	9.00	9.89	24.01	27.29	170.25
EV/Sales Ratio	3.50	2.03	1.17	2.17	3.63	3.22
EV/EBITDA Ratio	19.28	9.50	3.62	9.51	13.63	14.52
EV/EBIT Ratio	23.60	11.50	3.89	10.49	14.62	15.74
EV/FCF Ratio	37.43	9.80	11.09	-	104.29	1336.83
Debt / Equity Ratio	0.13	0.10	0.19	0.35	0.41	0.35
Debt / EBITDA Ratio	0.92	0.58	0.65	2.15	1.59	1.45
Debt / FCF Ratio	1.78	0.60	1.99	-	12.23	133.18
Asset Turnover	0.62	0.63	0.70	0.54	0.62	0.70
Inventory Turnover	3.04	2.04	2.46	2.06	2.03	2.86
Quick Ratio	1.60	0.88	0.99	0.74	0.73	0.86
Current Ratio	2.28	2.69	2.01	1.56	1.59	1.67
Return on Equity (ROE)	5.46%	10.06%	23.07%	12.77%	16.81%	17.06%
Return on Assets (ROA)	5.73%	6.89%	13.15%	7.02%	9.63%	8.98%
Return on Capital (ROIC)	6.43%	7.87%	15.28%	8.09%	10.98%	10.19%
Return on Capital Employed (ROCE)	11.50%	13.70%	25.40%	13.10%	21.70%	20.90%
Earnings Yield	1.98%	6.24%	19.85%	7.97%	4.79%	4.91%
FCF Yield	2.69%	10.51%	9.31%	-3.37%	0.97%	0.08%
Dividend Yield	1.60%	4.65%	8.88%	7.65%	3.53%	3.52%
Payout Ratio	125.65%	79.75%	34.81%	32.57%	72.85%	70.30%
Total Shareholder Return	1.60%	4.65%	8.88%	7.65%	3.53%	3.52%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.